# CVM GFI #279 Demonstrating Bioequivalence for Type A Medicated Articles Containing Active Pharmaceutical Ingredient(s) Considered to be Poorly Soluble in Aqueous Media, That Exhibit Little to No Systemic Bioavailability, and Are Locally Acting - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-279-demonstrating-bioequivalence-for-type-a-medicated-articles-containing-active-pharmaceutical-ingredients-considered-to-be-poorly-soluble-in-aqueous-media-that-exhibit-little-to-no-systemic-bioavailability-and-are-locally-acting/6563f603-dbc6-4d95-942f-0438c0f7d455

> FDA guidance document: CVM GFI #279 Demonstrating Bioequivalence for Type A Medicated Articles Containing Active Pharmaceutical Ingredient(s) Considered to be Poorly Soluble in Aqueous Media, That Exhibit Little to No Systemic Bioavailability, and Are Locally Acting. Issue date: June 21, 2024. Get complete insights and analysis.

---

## Details

- Title: CVM GFI #279 Demonstrating Bioequivalence for Type A Medicated Articles Containing Active Pharmaceutical Ingredient(s) Considered to be Poorly Soluble in Aqueous Media, That Exhibit Little to No Systemic Bioavailability, and Are Locally Acting
- Communication Type: Guidance Document
- Product Type: veterinary
- Office Name: Center for Veterinary Medicine
- Office URL: /offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4
- Issue Date: 2024-06-21
- Comment Close Date: 2023-10-16
- Last Changed: 2024-06-20
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2023-D-1275">FDA-2023-D-1275</a>

## Related Documents

- [CVM GFI #278 Human User Safety in New and Abbreviated New Animal Drug Applications](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-278-human-user-safety-in-new-and-abbreviated-new-animal-drug-applications/0a0c64dc-c687-44fe-b47c-72ab2723a713)
- [CVM GFI #261 - Eligibility Criteria for Expanded Conditional Approval of New Animal Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-261-eligibility-criteria-for-expanded-conditional-approval-of-new-animal-drugs/f14b98b9-4e54-4fbf-8ced-f5788ccefc39)
- [CVM GFI #272 Practices to Prevent Unsafe Contamination of Animal Feed from Drug Carryover](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-272-practices-to-prevent-unsafe-contamination-of-animal-feed-from-drug-carryover/335e5317-2d85-4437-9111-0208112a6240)